Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Peds CHAMP1ON - Combinatorial Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade Phase 1 Trial for RecurreNt Pediatric High-Grade Glioma

NCT07031765 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT07031765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07031765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Peds CHAMP1ON - Combinatorial Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade Phase 1 Trial for RecurreNt Pediatric High-Grade Glioma
Lead sponsor
University of Florida
Phase
Phase 1
Overall status
Active, not recruiting
Start date
July 25, 2025
Completion date
December 31, 2032
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ependymoma, grade iii astrocytoma, grade iv astrocytoma, oligoastrocytoma, oligodendroglioma, recurrent high-grade glioma